 |
|
|
| |
Identification and Characterization of VCH-222, a Novel Potent and Selective Non-Nucleoside HCV Polymerase Inhibitor
|
| |
| |
44th EASL April 23-26 2009 Copenhagen
Reported by Jules Levin
J. Bedard, O. Nicolas, D. Bilimoria, L. L'Heureux, P. Fex, M. David and L. Chan
ViroChem Pharma Incorporated, Laval, QC, Canada
Supported by ViroChem Pharma Incorporated, a wholly-owned subsidiary of Vertex Pharmaceuticals Incorporated
|
| |
|
|
|
|
|
